. Neurodegenerative and neuroinflammatory changes in SOD1-ALS patients receiving tofersen. Sci Rep. 2025 Apr 1;15(1):11034. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.